Difference between revisions of "Alpha-2 plasmin inhibitor (TG2)"
(New page: {{subst:infobox}}) |
|||
| Line 1: | Line 1: | ||
| − | |||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
| Line 12: | Line 11: | ||
|- | |- | ||
| Determination type | | Determination type | ||
| − | | In | + | | In vitro |
|- | |- | ||
| Source | | Source | ||
| Line 18: | Line 17: | ||
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
| − | | | + | | Extracellular; plasma |
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
| − | | [http://au.expasy.org/uniprot/ | + | | [http://au.expasy.org/uniprot/P08697 P08697 ] |
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | [[ | + | | [[Q2 (API)|Q2]] |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| − | | | + | | - |
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| − | | | + | | N''Q''EEVSP |
| + | |||
|- | |- | ||
| Structure | | Structure | ||
| − | | | + | | No available crystal structure |
| + | |||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 42: | Line 43: | ||
|- | |- | ||
| Reference | | Reference | ||
| − | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=10958788&dopt=Abstract PMID:10958788] |
|- | |- | ||
| Notes | | Notes | ||
Revision as of 13:03, 17 July 2007
| Template:Infobox header| Alpha-2 plasmin inhibitor (TG2) | |
|---|---|
| Alpha-2 plasmin inhibitor (TG2) | |
| Substrate peptide name | Alpha-2 plasmin inhibitor (TG2) |
| Synonyms | - |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma |
| Swissprot ID | P08697 |
| Reactive glutamines | Q2 |
| Reactive lysines | - |
| Substrate sequence | NQEEVSP |
| Structure | No available crystal structure |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:10958788 |
| Notes | |
| Template:Infobox header | | |
.png){kind=link}